Candidates should have an outstanding record of cancer research achievement focusing on basic molecular and cellular mechanisms, molecular therapeutics, or specific disease models. Researchers with expertise using chemical genetic or chemical genomic approaches, including but not limited to state-of-the-art techniques for identifying small molecules directed at cancer targets, in vitro and in vivo methods to enhance molecular target validation, and techniques for identifying and validating cancer biomarkers are encouraged to apply. Ph.D. or M.D. and postdoctoral research experience.